Drugs are produced in a variety of methods including by chance; after extensive testing of animals, plants and fungi; by studying the features of growing cells; by assessing the chemical makeup of a drug target; and through other clinical trials. The drug development process starts after a prospective medicine is found.
The essential phases of the drug development process are:
This phase looks into the discovered chemical to determine whether it has the potential to become a treatment.
The new treatment has been developed and/or manufactured in sufficient quantities to proceed with preclinical and clinical studies. After this time, preclinical studies are conducted to gather information on safety and pharmacology. This phase investigates the new drug’s influence on blood and tissues in order to assess its suitability for the intended use.
The necessary regulatory agencies are contacted, and a request for Investigational New Drug (IND) approval is lodged. The drug can only be provided to individuals when it has received an IND authorization.
This phase is branched into three sub-phases:
- The drug is tested on a few hundred healthy volunteers in the first sub-phase to determine dosage and effect.
- During the second sub-phase, the drug is tested on a larger number of volunteers for the scrutinization of efficacy and adverse effects. These participants must have the medical condition that this drug is used to address.
- In the third phase, the product is administered to a broader number of patients, ranging from a few hundred to several thousand. This stage further aids in determining the drug’s efficacy and safety; during this time, placebos are handed out to compare the results.
The premarketing process begins at the first sub-phase of clinical research. This is done to ensure that the new pharmaceutical is suitable for the expectations of the market. Each of the three subphases follows the same pattern. During the final step, the drug is promoted in worldwide symposiums. Medical experts will become more aware of drugs as a result of this move.
Suppose the trials in the last phase of clinical development are successful. In that case, an application for approval of the new pharmaceutical is filed to the appropriate regulatory body in the country where the drug was manufactured. Before the drug can be marketed, it must have this approval.
Patients are given the advertised drug and are monitored on a regular basis throughout this period. This allows the drug to be enhanced, used in different conditions, contrasted with other medicines, and assessed for effectiveness.
Contact Rondaxe online or by calling (315) 469-2800 for more information on the drug production process.